These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28651490)

  • 1. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
    Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM
    Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
    Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total alkaloids of Rubus alceifolius Poir inhibit tumor angiogenesis through suppression of the Notch signaling pathway in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Zhuang Q; Zheng L; Peng J; Hong Z
    Mol Med Rep; 2015 Jan; 11(1):357-61. PubMed ID: 25333354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
    Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
    Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma.
    Adachi Y; Matsuki M; Watanabe H; Takase K; Kodama K; Matsui J; Funahashi Y; Nomoto K
    Cancer Invest; 2019; 37(4-5):185-198. PubMed ID: 31006280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.
    Piccioni F; Fiore E; Bayo J; Atorrasagasti C; Peixoto E; Rizzo M; Malvicini M; Tirado-González I; García MG; Alaniz L; Mazzolini G
    Glycobiology; 2015 Aug; 25(8):825-35. PubMed ID: 25882295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
    Jung KH; Zheng HM; Jeong Y; Choi MJ; Lee H; Hong SW; Lee HS; Son MK; Lee S; Hong S; Hong SS
    Cancer Lett; 2013 Jan; 328(1):176-87. PubMed ID: 22902995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor.
    Yun SM; Lee JH; Jung KH; Lee H; Lee S; Hong S; Hong SS
    Int J Oncol; 2013 Jul; 43(1):201-9. PubMed ID: 23604199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of VEGF/VEGFR/K-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats.
    Gao JZ; Wang YL; Li J; Wei LX
    Genet Mol Res; 2015 Jan; 14(1):671-9. PubMed ID: 25730004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM; Gebhard DF; Andresen CJ
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
    Hsu C; Chen CN; Chen LT; Wu CY; Hsieh FJ; Cheng AL
    Radiology; 2005 May; 235(2):509-16. PubMed ID: 15858091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats.
    Elsonbaty SM; Zahran WE; Moawed FS
    Tumour Biol; 2017 Aug; 39(8):1010428317708703. PubMed ID: 28810822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshindiol-C suppresses in vitro and in vivo hepatocellular cancer cell growth by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of angiogenesis and modulation of key tumor-suppressive miRNAs.
    Zhou P; Cheng Y; Liu F; Wu K; Qiu W; Wang S
    J BUON; 2019; 24(2):622-627. PubMed ID: 31128015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastrus orbiculatus extract inhibits tumor angiogenesis by targeting vascular endothelial growth factor signaling pathway and shows potent antitumor activity in hepatocarcinomas in Vitro and in Vivo.
    Qian YY; Zhang H; Hou Y; Yuan L; Li GQ; Guo SY; Hisamits T; Liu YQ
    Chin J Integr Med; 2012 Oct; 18(10):752-60. PubMed ID: 21805294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.